Microglia are the major immune cells of our brain and play a key role in Alzheimer’s disease. Microglia clear brain waste that otherwise can become toxic, and also support other cell types, such as neurons. In Alzheimer’s disease, microglia become dysregulated and overactivated, leading to a toxic cycle of neuroinflammation. ...
January 12, 2024
March 27, 2019
Boston October Symposium To Educate Public on Alzheimer’s Disease Wellesley, Mass.–Local hairdresser and salon owner Barbara Canty knows the toll that Alzheimer’s Disease can take on a family. Five years ago, Canty’s father was diagnosed with Alzheimer’s, and her experience caring for him has made her realize the importance of ...
October 11, 2011
January 30, 2024
The U.S. Food and Drug Administration recently approved aducanumab, an antibody that promotes clearance of amyloid beta plaques in patients with Alzheimer’s disease. Here we propose to study whether Alzheimer’s disease is associated with the development of natural antibodies against amyloid beta plaques, whether these antibodies attenuate disease progression and ...
February 11, 2022
Dear Friends, It is rare to have an opportunity to combine a personal passion with something critical to the future of your family. Over the past year, I was fortunate to combine my passion for mountain climbing with a global effort to raise awareness and money for Alzheimer’s research. The Road ...
July 22, 2008
January 30, 2024
April 24, 2019
October 6, 2023
Sam Gandy, M.D., Ph.D., of the Icahn School of Medicine at Mount Sinai is leading an international team of researchers working to reprogram skin cells into brain cells to gain a better understanding of Alzheimer’s disease (AD). As part of the consortium, Dr. Gandy is collaborating with Scott Noggle, Ph.D., ...
March 28, 2013
